RecruitingNCT06494228

Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis


Sponsor

University Hospital, Strasbourg, France

Enrollment

60 participants

Start Date

Jan 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Ultimately improve the care of patients suffering from multiple sclerosis (1st cause of acquired non-traumatic disability in adults) and NMO spectrum diseases by using more efficient MRI sequences than the FLAIR sequence commonly used in detection of optic neuritis. In the literature, many studies have already focused on comparing the sensitivity of detection of white matter demyelination plaques using FLAIR, PSIR or DIR sequences. Some authors have shown better sensitivity of the PSIR sequence in the detection of demyelinating lesions of the marrow in multiple sclerosis compared to conventional sequences. Others have shown better performance of the combined use of PSIR and DIR sequences compared to the FLAIR sequence in the detection of cortical lesions in multiple sclerosis. However, in the context of optic neuritis, few comparative studies comparing these three sequences have been carried out: A 2022 study showed better diagnostic sensitivity of optic neuritis of the DIR sequence compared to the FLAIR sequence. A possible better diagnostic performance of a sequence not used in current practice in the detection of optic neuritis (PSIR and DIR sequences), would be possible to justify their use on a larger scale and ultimately improve patient care.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a diagnostic imaging study looking at which MRI technique (3D FLAIR, DIR, or PSIR) is best at detecting damage in the optic nerve of people with multiple sclerosis or a related condition called neuromyelitis optica spectrum disorder. **You may be eligible if...** - You are 18 or older - You have a diagnosis of multiple sclerosis or neuromyelitis optica spectrum disorder - You had an MRI scan between April 2019 and November 2021 that included all three imaging sequences being studied - You have not objected to your existing data being used for research **You may NOT be eligible if...** - You have formally objected to your medical data being used for research - Your MRI images had too many technical artifacts to be interpreted Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Service de Radiologie II, CHU de Strasbourg

Strasbourg, Les Hôpitaux Universitaires de Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06494228


Related Trials